Centessa Pharmaceuticals (CNTA)
undefined
undefined%
At close: undefined
16.57
-0.06%
After-hours Dec 13, 2024, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20
Cash & Equivalents 128.03M 393.64M 595.08M 7.23M
Short-Term Investments 128.52M - - -
Long-Term Investments - - - -
Other Long-Term Assets 2.55M 45.98M 34.39M 552.00K
Receivables 39.15M 26.72M 16.81M -
Inventory 1.00 -29.99M -17.81M 1.00M
Other Current Assets 19.39M 17.38M 16.88M 3.94M
Total Current Assets 315.09M 393.64M 595.08M 11.16M
Property-Plant & Equipment 12.95M 1.17M 162.00K -
Goodwill & Intangibles - - - -
Total Long-Term Assets 45.15M 50.66M 34.55M 552.00K
Total Assets 360.25M 444.31M 629.63M 11.72M
Account Payables 11.81M 13.84M 7.30M 1.03M
Deferred Revenue - - - 1.04M
Short-Term Debt - - - 5.63M
Other Current Liabilities 27.46M 22.92M 16.57M 1.96M
Total Current Liabilities 39.38M 38.34M 24.64M 8.62M
Long-Term Debt 84.59M 69.80M 75.70M -
Other Long-Term Liabilities 29.00K - 37.74M -
Total Long-Term Liabilities 84.62M 108.14M 138.08M 25.52M
Total Liabilities 124.00M 108.14M 138.08M 34.14M
Total Debt 84.59M 69.80M 75.70M 5.63M
Common Stock 273.00K 265.00K 252.00K 21.00K
Retained Earnings -752.95M -601.86M -385.65M -22.42M
Comprehensive Income 1.49M -1.50M 688.00K -86.00K
Shareholders Equity 236.24M 336.17M 491.55M -22.42M
Total Investments 128.52M - - -